As of 2025-09-15, the Relative Valuation of Evelo Biosciences Inc (EVLO) is (23,545.41) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.32 USD, the upside of Evelo Biosciences Inc based on Relative Valuation is -7439406.7%.
The range of the Relative Valuation is (18,616.66) - (31,027.76) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.4x - 11.3x | 7.8x |
| Forward P/E multiples | 6.8x - 11.8x | 9.3x |
| Fair Price | (18,616.66) - (31,027.76) | (23,545.41) |
| Upside | -5882140.8% - -9803501.3% | -7439406.7% |
| Date | P/E |
| 2025-09-03 | -0.00 |
| 2025-08-29 | -0.00 |
| 2025-08-26 | -0.00 |
| 2025-08-21 | -0.00 |
| 2025-08-19 | -0.00 |
| 2025-08-15 | -0.00 |
| 2025-07-31 | -0.00 |
| 2025-07-30 | -0.00 |
| 2025-07-23 | -0.00 |
| 2025-07-21 | -0.00 |
| 2025-07-18 | -0.00 |
| 2025-07-16 | -0.00 |
| 2025-07-10 | -0.00 |
| 2025-07-09 | -0.00 |
| 2025-07-02 | -0.00 |
| 2025-06-17 | -0.00 |
| 2025-06-16 | -0.00 |